All News

Using FIB-4 index first to screen for cirrhosis may lead to clinicians missing 48% of cases, according to a recent study.

Your daily dose of the clinical news you may have missed.

Preventive health screenings have yet to rebound to pre-COVID-19 levels and Asian adults appear to have fallen behind more than other racial/ethnic groups, a new study finds.

Mean placebo-adjusted SBP change from baseline at 36 weeks was 8.6 mm Hg in adults with obesity, according to authors of the SURMOUNT-1 ABPM substudy.

Reported cases of chlamydia, syphilis, and gonorrhea in the US surpassed 2.5 million for the third time in 5 years, according to CDC.

Access to methadone and buprenorphine treatment may be easier and incentive to continue treatment could start at home, using telehealth, according to HHS.

Your daily dose of the clinical news you may have missed.

The combination SABA/ICS inhaler is the first of its kind and treats both acute bronchoconstriction and the inflammation that drives asthma and disease exacerbation.

The updated COVID-19 vaccines were approximately 54% effective against symptomatic SARS-CoV-2 infection, according to new data from the CDC.

The 3-fold greater risk of subsequent stroke was observed in the Black Women's Health Study's youngest cohort, aged 24-34, investigators reported.

Your daily dose of the clinical news you may have missed.

Eating disorders among US youth spiked during the COVID-19 pandemic, but a new study shows hospitalizations have been inching up for a decade or more.

The risk of cough and asthma in persons with severe depression was 3.32 times and 2.84 times higher, respectively, than that in those without depression, reported researchers.

After March 8, 2024, EUA-labeled Paxlovid will no longer be authorized for use, regardless of expiration date, according to the agency.

Past month use of cannabis was associated with 43% greater odds of asthma than no use of the drug; odds were 2-fold greater with use of blunts.

Your daily dose of the clinical news you may have missed.

Risk of mortality from ALD and MetALD was significantly higher among women even though both phenotypes were more prevalent among men, a new study reveals.

Reported adverse events of products with tianeptine include seizures, loss of consciousness, and death, according to the FDA.